Clinical Trials Logo

Clinical Trial Summary

The overall goal of this study is to facilitate care improvements for bladder cancer patients with locally advanced or metastatic disease by designing and evaluating a patient need assessment screening tool to be used, in the future, as standard screening measure. Adult individuals diagnosed with Stage 4 incurable locally advanced or metastatic bladder cancer will be included in this study and asked to participate in a focus group, complete a screening tool, or complete a survey. All data collected will be linked to a study ID number and HIPAA identifiers will not be linked to study data. Identifying information (ie: name, mrn, email, phone number) will be utilized for study recruitment and identifying eligible patients. Any disclosure of the human subjects' responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability, educational advancement, or reputation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06412874
Study type Observational
Source Icahn School of Medicine at Mount Sinai
Contact Talia Korn, MA
Phone 212-241-4983
Email Talia.Korn@mountsinai.org
Status Recruiting
Phase
Start date September 1, 2023
Completion date November 2025

See also
  Status Clinical Trial Phase
Completed NCT00588211 - Measurement of Cancer-Related Risk Perception in Smokers